InsidersTradesSigma
Track the Anthem Biosciences Limited share price and the full directors' dealings record of the company, a publicly traded company based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Anthem Biosciences Limited has logged 3 public disclosures. Market capitalisation: €443.8bn. The latest transaction was disclosed on 11 March 2026 (Sale). Among the most active insiders: Viridity Tone LLP. All data is openly available.
Analysts rate Anthem Biosciences Limited Strong Buy (bullish), based on 7 analysts. Average price target: ₹884.43.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Anthem Biosciences Limited is a company in the health and pharmaceutical sector, providing biotechnology and research services. It is listed on the XBOM.